AdVince reaches Clinical Trials

Featured Image

A virus which fights cancer: we are pleased to announce that the Medical Product Agency (the regulatory body in Sweden) and the Regional Ethics Committee have approved the initiation of a phase I/IIa clinical trial with AdVince for patients with neuroendocrine cancer. The AdVince virus was produced with money obtained through donations to Uppsala University's Oncolytic Virus Fund. The Anglo-Swedish Society is the Fund's official UK fundraising partner. SEE VIDEO